| AZ | EN | RU


CHARACTERISTICS OF PERIPHERAL ARTERY ATHEROSCLEROSIS IN PATIENTS WITH DIABETES MELLITUS
Mehdiyev S.Kh.


DOI: 10.61775/2413-3302.v1i43.15


SUMMARY
Atherosclerotic involvement of peripheral arteries is a common and often subclinical vascular complication in patients with type 2 diabetes mellitus and is associated with an increased risk of cardiovascular events. The aim of this study was to assess the relationship between the ankle-brachial index, as a subclinical marker of peripheral atherosclerosis, and cardiovascular risk factors, glycemic control, arterial hypertension, microalbuminuria, and sonographic parameters of lower limb arteries in patients with type 2 diabetes mellitus in the Azerbaijani population. Material and Methods. The study included 528 patients aged 30–69 years with type 2 diabetes mellitus. Patients were evaluated using questionnaire data, physical examination, glycated hemoglobin level, microalbuminuria, blood pressure measurements, and sonographic assessment of lower limb arteries. The ankle-brachial index was used as an objective indicator of peripheral artery disease, and an ABI value ≤0.9 was considered evidence of peripheral arterial involvement. Results. The mean ABI value was 1.061±0.009, while ABI<0.9 was detected in 27.2% of patients. Clinical signs of lower limb atherosclerosis were observed in 66.7% of patients. Inadequate glycemic control was associated with a higher frequency of ABI≤0.9 and more pronounced impairment of peripheral circulation. The severity of stenosis increased toward the distal arterial segments, with signs of decompensation mainly observed in the below-knee–ankle segment. Patients with arterial hypertension had significantly lower ABI values and a higher frequency of peripheral atherosclerosis compared with normotensive patients. Increasing microalbuminuria was also associated with a higher prevalence of peripheral atherosclerotic changes. Conclusion. In patients with type 2 diabetes mellitus, the ankle-brachial index may be used as a practical screening marker for peripheral artery disease and cardiovascular risk assessment.
Keywords: type 2 diabetes mellitus, Ramadan, fasting, hypoglycemia, DPP-4 inhibitors, insulin therapy, IDF/DAR score


REFERENCES
  1. Kumar MS, Lohiya A, Ramesh V, Behera P, et al. Sensitivity and Specificity of Pulse Oximetry and Ankle-Brachial Index for Screening Asymptomatic Peripheral Vascular Diseases in Type 2 Diabetes Mellitus // J Assoc Physicians India. 2016 Aug;64(8):38-43
  2. Sartore G, Caprino R, Ragazzi E, Bianchi L, et al. The ankle-brachial index for assessing the prevalence of peripheral artery disease and cardiovascular risk in patients with type 2 diabetes mellitus // Nutr Metab Cardiovasc Dis. 2023 Mar;33(3):560-567. doi: 10.1016/j.numecd.2022.11.019
  3. Alves-Cabratosa L, Comas-Cufí M, Ponjoan A, Garcia-Gil M, et al. Levels of ankle-brachial index and the risk of diabetes mellitus complications // BMJ Open Diabetes Res Care. 2020 Mar;8(1):e000977. doi: 10.1136/bmjdrc-2019-000977
  4. Doza B, Kaur M, Chopra S, Kapoor R. Cardiovascular Risk Factors and Distributions of the Ankle-Brachial Index among Type 2 Diabetes Mellitus Patients // Int J Hypertens. 2012;2012:485812. doi: 10.1155/2012/485812
  5. Nie F, He J, Cao H, Hu X. Predictive value of abnormal ankle-brachial index in patients with diabetes: A meta-analysis // Diabetes Res Clin Pract. 2021 Apr;174:108723. doi: 10.1016/j.diabres.2021.108723
  6. Makhdoomi K, Mohammadi A, Yekta Z, Aghasi MR, et al. Correlation between ankle-brachial index and microalbuminuria in type 2 diabetes mellitus // Iran J Kidney Dis. 2013 May;7(3):204-9
  7. Niwa H, Takahashi K, Dannoura M, Oomori K, et al. The Association of Cardio-Ankle Vascular Index and Ankle-Brachial Index with Macroangiopathy in Patients with Type 2 Diabetes Mellitus // J Atheroscler Thromb. 2019 Jul 1;26(7):616-623. doi: 10.5551/jat.45674
  8. Yang MC, Huang YY, Hsieh SH, Sun JH, et al. Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2021 Nov 18;12:752995. doi: 10.3389/fendo.2021.752995